What Sets Our Cancer Program Apart?
The Hematology / Oncology Division at Cincinnati Children's Hospital Medical Center is a leader because:
Our cancer center is one of the nation's leading clinical research centers for pediatric cancer.
Cincinnati Children's cancer program conducts cutting-edge clinical research initiatives.
- Gene therapy for high-risk brain tumors
- Targeted virus therapy for neuroblastoma and solid tumors
- Radiation targeted therapies for neuroblastoma, leukemias and lymphomas
- Novel high-dose chemotherapy and antibody approaches for leukemias, neuroblastoma, relapsed brain tumors and other pediatric cancers
The program has many areas of clinical and research expertise.
The division at Cincinnati Children's has multidisciplinary, disease-specific teams.
Team members of the Hematology / Oncology Division at Cincinnati Children's are leaders in major professional organizations.
The division is affiliated with the Division of Experimental Hematology at Cincinnati Children's, which conducts basic and translational research.
- Molecular and gene therapy
- Cell signaling
- Leukemia biology
- Stem cell biology
